Direct-to-Consumer marketing can work for some ortho companies but it is nuanced.

5 Jul 2025 · 1 min
0:32

In this segment, Tiger Buford argues that most patients are unable to accurately self‑diagnose orthopedic conditions, making direct‑to‑consumer (DTC) marketing ineffective for many medical‑device companies. He explains that DTC only makes sense when a condition is readily recognizable by the patient, allowing them to request a specific product from a surgeon. He cites the preventative hernia device "Barricade" as an example where patients could identify a future need and seek the product. Buford emphasizes that device makers must employ highly specific targeting strategies, directing consumers to a surgeon‑finder tool only when the patient can precisely articulate the needed device.

Chapters

More from Tiger

1:00:35
youtube.com

BoneChat #146 - Raising Capital, Protecting Equity, Dilution & Staying Lean

2w ago
58:35
youtube.com

BoneChat #145 - ASC Robots, Direct-to-Patient Marketing & Ortho Startup Reality

3w ago
57:20
youtube.com

BoneChat #144 - Defining the Standard of Care for Orthopedic Tissue Preservation & Restoration

4w ago
56:40
youtube.com

BoneChat #143 - AI-Driven MedTech Sales, Startup Traps, & Orthopedic Commercialization

1mo ago
1:20
youtube.com

Reverse Shoulder movement in the US

1mo ago
1:03:29
youtube.com

BoneChat #142 - Fastest-Growing Ortho Segments, Reverse Shoulder & Joint Preservation Rollups

1mo ago
59:10
youtube.com

BoneChat #141 - Disrupting Surgical Visualization: Single-Use 4K Scopes with Richard McKillop

1mo ago
57:56
youtube.com

BoneChat #140 - Transforming Knee Rehab, Patient Experience, and MedTech Go-to-Market

1mo ago
0:36
youtube.com

How to find early adopters in Ortho.

2mo ago
0:35
youtube.com

The Importance of Controlling Your Own Destiny in Deals

2mo ago
0:50
youtube.com

Red Flags in Business Partnerships

2mo ago
See all content